Sun Pharmaceutical Industries Limited — Board Meeting, 05-11-2025: Outcome of Board Meeting
05-11-2025 | 04:05 pm
05-11-2025 | 04:05 pm
Sun Pharma's Board approved the financial results for the quarter and half-year. Q2 consolidated sales hit ₹14,405 Cr (+8.6% YoY) & net profit ₹3,118 Cr (+2.6% YoY). Board also OK'd amending MoA for captive solar/renewable energy. Innovative Medicines sales grew 16.4%, surpassing US Generics. #SunPharma #Q2Results
No comments yet. Be the first to comment!
All announcements from Sun Pharmaceutical Industries Limited
